Mandatory disclosure of pharmaceutical industry-funded events for health professionals.
Guardado en:
Autores principales: | Jane Robertson, Ray Moynihan, Emily Walkom, Lisa Bero, David Henry |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41179e5ea98d4c5893ce072a52729971 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MANDATORY LABELLING OF NANOFOODS AND THE WTO AGREEMENTS
por: Nor Akhmal Hasmin, et al.
Publicado: (2020) -
Forming impressions of facial attractiveness is mandatory
por: Kay L. Ritchie, et al.
Publicado: (2017) -
CONTINUOUS PROFESSIONAL DEVELOPMENT OF PERSONNEL FOR THE PHARMACEUTICAL SECTOR
por: N. V. Pyatigorskaja, et al.
Publicado: (2012) -
The effect of IFRS mandatory adoption on the information asymmetry
por: Hela Turki, et al.
Publicado: (2016) -
How Covid19 affects the stock return of the Vietnamese pharmaceutical industry: event study method
por: Lai Cao Mai Phuong
Publicado: (2021)